Document Detail

Localized unilateral hyperhidrosis and neurofibromatosis type 1: case report of a new association.
MedLine Citation:
PMID:  16205077     Owner:  NLM     Status:  MEDLINE    
Localized unilateral hyperhidrosis (LUH) is an uncommon but well-defined special form of localized hyperhidrosis with diverse causes. It often occurs within a sharply demarcated area on the face or upper extremities. Here, we report a case of LUH in a 16-year-old male with neurofibromatosis type 1 (NF1) and review related data in the literature. The association of this rare entity and NF1 has not yet been described. Subcutaneous botulinum toxin A injection provided a good clinical response with symptomatic relief.
Emel Bulbul Baskan; Necdet Karli; Mehmet Baykara; Semra Cikman; Sukran Tunali
Related Documents :
2859377 - Anaesthetic ejaculation.
10566397 - Modeling empiric antibiotic therapy evaluation of qid.
15929497 - Chronic fatigue syndrome: the need for subtypes.
627227 - Urethro-balanitis xerotica obliterans.
16569267 - Commercial watercress as an emerging source of fascioliasis in northern france in 2002:...
2714687 - Primary atypical mycobacteriosis of the intestine: a report of three cases.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Dermatology (Basel, Switzerland)     Volume:  211     ISSN:  1018-8665     ISO Abbreviation:  Dermatology (Basel)     Publication Date:  2005  
Date Detail:
Created Date:  2005-10-05     Completed Date:  2006-01-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203244     Medline TA:  Dermatology     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  286-9     Citation Subset:  IM    
Copyright Information:
Copyright 2005 S. Karger AG, Basel.
Department of Dermatology, Uludag University Medical Faculty, Bursa, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Botulinum Toxin Type A / administration & dosage
Hyperhidrosis / complications,  drug therapy*
Injections, Subcutaneous
Neurofibromatosis 1 / complications*
Neuromuscular Agents / administration & dosage
Treatment Outcome
Reg. No./Substance:
0/Botulinum Toxin Type A; 0/Neuromuscular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement.
Next Document:  A case of lupus vulgaris successfully treated with antituberculous therapy despite negative PCR and ...